Article PDF
References
Goldrirsch A, Ingle JN, Gelber RD et al (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus of the primary therapy of early breast cancer 2009. Ann Oncol 20:1319–1329
Perou CM, Sorlie T, Elsen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752
Prat A, Perou CM (2011) Deconstructing the molecular portraits of breast cancer. Molec Oncol 5:5–23
Goldrirsch A, Wood WC, Coates AS; panel members (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2011. Ann Oncol 22:1736–1747
Albanell J, Gonzalez A, Ruiz Borrego M et al (2011) Prospective transGEICAM study of the impact of the 21-Gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision-making in women with estrogen receptor-positive (ER+) node-negative breast cancer. Ann Oncol [Epub ahead of print] doi: 10.1093/annonc/mdr278
Aaronson DS, Horvath CM (2002) A road map of those who don’t know JAK-STAT. Science 296:1653–1655
Tweardy D, Chang JC (2011) Stat5: from breast development to cancer prognosis, prediction and progression. J Clin Oncol 29:2443–2444
Yamasmita H, Nishio M, Ando Y et al (2006) Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer. Endocr Relat Cancer 13:885–893
Dolled-Filhart M, Camp RL, Kowalski DP et al (2003) Tissue microarray analysis of signal transducer and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear location is associated with a better prognosis. Clin Cancer Res 9:594–600
Sonnenblick A, Shriki A, Galun E et al (2012) Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis. Clin Transl Oncol 14:232–236
Marotta LC, Almendro V, Marusyk A et al (2011) The JAK2/STAT3 signalling pathway is required for growth of CD44+CD24-stem cell-like breast cancer cells in human tumors. J Clin Investig 121:2723–2735
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barnadas, A. Is there any role for new prognostic markers in breast cancer?. Clin Transl Oncol 14, 161–162 (2012). https://doi.org/10.1007/s12094-012-0778-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-012-0778-2